Literature DB >> 6950406

Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells.

G R Martin.   

Abstract

This report describes the establishment directly from normal preimplantation mouse embryos of a cell line that forms teratocarcinomas when injected into mice. The pluripotency of these embryonic stem cells was demonstrated conclusively by the observation that subclonal cultures, derived from isolated single cells, can differentiate into a wide variety of cell types. Such embryonic stem cells were isolated from inner cell masses of late blastocysts cultured in medium conditioned by an established teratocarcinoma stem cell line. This suggests that such conditioned medium might contain a growth factor that stimulates the proliferation or inhibits the differentiation of normal pluripotent embryonic cells, or both. This method of obtaining embryonic stem cells makes feasible the isolation of pluripotent cells lines from various types of noninbred embryo, including those carrying mutant genes. The availability of such cell lines should made possible new approaches to the study of early mammalian development.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6950406      PMCID: PMC349323          DOI: 10.1073/pnas.78.12.7634

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  13 in total

1.  The culture of cells derived from mouse blastocysts.

Authors:  M I Sherman
Journal:  Cell       Date:  1975-08       Impact factor: 41.582

2.  Teratocarcinomas rarely develop from embryos transplanted into athymic mice.

Authors:  D Solter; I Damjanov
Journal:  Nature       Date:  1979-04-05       Impact factor: 49.962

3.  The development of transplantable teratocarcinomas from intratesticular grafts of pre- and postimplantation mouse embryos.

Authors:  L C Stevens
Journal:  Dev Biol       Date:  1970-03       Impact factor: 3.582

4.  Immunosurgery of mouse blastocyst.

Authors:  D Solter; B B Knowles
Journal:  Proc Natl Acad Sci U S A       Date:  1975-12       Impact factor: 11.205

5.  Gene expression in neoplasia and differentiation.

Authors:  B Mintz
Journal:  Harvey Lect       Date:  1978

6.  Incorporation of teratocarcinoma stem cells into blastocysts by aggregation with cleavage-stage embryos.

Authors:  J T Fujii; G R Martin
Journal:  Dev Biol       Date:  1980-01       Impact factor: 3.582

7.  The development of cystic embryoid bodies in vitro from clonal teratocarcinoma stem cells.

Authors:  G R Martin; L M Wiley; I Damjanov
Journal:  Dev Biol       Date:  1977-12       Impact factor: 3.582

8.  Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1).

Authors:  D Solter; B B Knowles
Journal:  Proc Natl Acad Sci U S A       Date:  1978-11       Impact factor: 11.205

9.  Differentiation of clonal lines of teratocarcinoma cells: formation of embryoid bodies in vitro.

Authors:  G R Martin; M J Evans
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

10.  Normal genetically mosaic mice produced from malignant teratocarcinoma cells.

Authors:  B Mintz; K Illmensee
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

View more
  1397 in total

Review 1.  Modification and repression of genes expressed in the mammary gland using gene targeting and other technologies.

Authors:  J L Vilotte; P L'Huillier; J C Mercier
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-07       Impact factor: 2.673

2.  Phenotypic complementation establishes requirements for specific POU domain and generic transactivation function of Oct-3/4 in embryonic stem cells.

Authors:  Hitoshi Niwa; Shinji Masui; Ian Chambers; Austin G Smith; Jun-ichi Miyazaki
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

Review 3.  From teratocarcinomas to embryonic stem cells.

Authors:  Peter W Andrews
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2002-04-29       Impact factor: 6.237

Review 4.  [Tissue engineering in urology. Basic principles and application].

Authors:  G Bartsch; A Atala
Journal:  Urologe A       Date:  2003-02-28       Impact factor: 0.639

5.  Genetic engineering of mouse embryonic stem cells by Nurr1 enhances differentiation and maturation into dopaminergic neurons.

Authors:  Sangmi Chung; Kai-C Sonntag; Therese Andersson; Lars M Bjorklund; Jae-Joon Park; Dong-Wook Kim; Un Jung Kang; Ole Isacson; Kwang-Soo Kim
Journal:  Eur J Neurosci       Date:  2002-11       Impact factor: 3.386

6.  Gene expression profiling of embryo-derived stem cells reveals candidate genes associated with pluripotency and lineage specificity.

Authors:  Tetsuya S Tanaka; Tilo Kunath; Wendy L Kimber; Saied A Jaradat; Carole A Stagg; Masayuki Usuda; Takashi Yokota; Hitoshi Niwa; Janet Rossant; Minoru S H Ko
Journal:  Genome Res       Date:  2002-12       Impact factor: 9.043

Review 7.  Deconstructing and reconstructing the mouse and human early embryo.

Authors:  Marta N Shahbazi; Magdalena Zernicka-Goetz
Journal:  Nat Cell Biol       Date:  2018-07-23       Impact factor: 28.824

8.  Structure-function Studies in Mouse Embryonic Stem Cells Using Recombinase-mediated Cassette Exchange.

Authors:  Tim Pieters; Lieven Haenebalcke; Kenneth Bruneel; Niels Vandamme; Tino Hochepied; Jolanda van Hengel; Dagmar Wirth; Geert Berx; Jody J Haigh; Frans van Roy; Steven Goossens
Journal:  J Vis Exp       Date:  2017-04-27       Impact factor: 1.355

Review 9.  The role of connexins during early embryonic development: pluripotent stem cells, gene editing, and artificial embryonic tissues as tools to close the knowledge gap.

Authors:  Philipp Wörsdörfer; Nicole Wagner; Süleyman Ergün
Journal:  Histochem Cell Biol       Date:  2018-07-23       Impact factor: 4.304

10.  Stem cell grafting improves both motor and cognitive impairments in a genetic model of Parkinson's disease, the aphakia (ak) mouse.

Authors:  Jisook Moon; Hyun-Seob Lee; Jun Mo Kang; Junpil Park; Amanda Leung; Sunghoi Hong; Sangmi Chung; Kwang-Soo Kim
Journal:  Cell Transplant       Date:  2012-10-02       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.